We have observed
17 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 20, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Phosphine oxide, a process for the manufacture thereof and application thereof
(E)-3-Aryl-3-oxoprop-1-enyl-2-phosphonic acid and its derivatives, methods for their preparation and their use
The use of ionic salts containing phosphonium cation
1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
10-Thiosubstituted pentahydroxyanthracene derivatives, a method of their preparation and intermediate compounds
The use of the ionic salts containing chiral alkylimidazolium cation and tetrafluoroborate anion
THE PROCESS OF PREPARING THE BROMINATED MULTI-WALLED CARBON NANOTUBES (MWCNT) CONTAINING BROMINE ATOMS AND THE WAY OF PURIFICATION THEM
Sorbent for receiving radionuclide arsenic-72, production of this sorbent and its use
3-ARYL-2-PHOSPHORYL SUBSTITUTED 1-INDANONES AND THE METHOD FOR THEIR PREPARATION
Method of obtaining and separating valuable metallic elements, specifically from low-grade uranium ores and radioactive liquid wastes
Halogen derivatives of benzo[b]furans useful as anti-neoplastic or anti-proliferative drugs
The medical use of 3-aryl substituted 1-indanones
A process for the manufacture of optically active phosphinamide
A selective extraction of uranium and Protactinium from material containing thorium
USE OF IONIC LIQUIDS BASED ON TERTIARY PHOSPHINE OXIDES DERIVATIVES WITH A TERMINAL AMINO GROUP
TRIPHENYLPHOSPHONIUM SALTS FOR USE IN CANCER THREAPY